Trihexosylceramide (d18:1/9Z-18:1)

(E)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octadec-9-enamide

XRPQSEBNLXORQZ-LSUSWXEESA-N CHEBI:180844 0 Reactome links 1 studies

Metabolite details

Identifier: XRPQSEBNLXORQZ-LSUSWXEESA-N
InChI Key: XRPQSEBNLXORQZ-LSUSWXEESA-N
IUPAC name: (E)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octadec-9-enamide
Preferred name: Trihexosylceramide (d18:1/9Z-18:1)
INN name: —
Synonym: —
ChEBI: CHEBI:180844

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii

Observed in differential profiles

Wild_type_vs_hfq
Wild_type_vs_hfq